Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The challenge of molecular medicine: complexity versus Occam’s razor
Eric A. Sobie, … , Long-Sheng Song, W.J. Lederer
Eric A. Sobie, … , Long-Sheng Song, W.J. Lederer
Published March 15, 2003
Citation Information: J Clin Invest. 2003;111(6):801-803. https://doi.org/10.1172/JCI18153.
View: Text | PDF
Commentary

The challenge of molecular medicine: complexity versus Occam’s razor

  • Text
  • PDF
Abstract

Authors

Eric A. Sobie, Silvia Guatimosim, Long-Sheng Song, W.J. Lederer

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Complexity of signaling in heart failure. Following an insult (e.g., a m...
Complexity of signaling in heart failure. Following an insult (e.g., a myocardial infarction), there are many changes in cellular and molecular signals and structure that occur as a primary consequence of that disturbance. Each of the signals and structural changes generated by the sequelae of the insult has many targets, including some earlier in the cascade. These changes in signaling and structure continue to propagate through secondary and later pathways. It is thus possible for therapeutic benefit to arise from interrupting (or augmenting) one of the pathways in the cascade, but it is equally possible for that same change to produce deleterious effects. The left red arrow represents the initial insult. The right red arrow represents a therapeutic intervention The X indicates that the therapeutic intervention may be a functional knockout or an augmentation of the function. Given the complexity of the pathways, the upstream and downstream sense of signaling may not be clear.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts